Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Cisplatin in Previously Untreated, Unresectable Invasive Thymoma or Thymic Carcinoma
NCT00818090Phase 2Terminated
- Sponsor
- Korean Cancer Study Group
- Start
- Sep 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in thymoma, thymic carcinoma (TC), sponsored by Korean Cancer Study Group. Started Sep 2008; status: terminated.
02
Drugs
paclitaxelcisplatin
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT00818090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818090.